Max Yusem
Paul Hastings LLPGeneral
Experience10 yrs
Elite Ratings
--
Practice Areas
Biotech (14 cases)
Chemical (3 cases)
Software, Security (1 case)
Chemical Biotech (1 case)
Ratings
Experience
Grade
Trend
DCT
L1
C
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 2:23-CV-00222 | CureVac Se v. BioNTech Se | 05/19/23 | Challenger | |
| 3:23-CV-01876 | Arbutus Pharma Corp v. Pfizer Inc | 04/04/23 | Challenger | |
| 1:21-CV-01478 | San Rocco Therap LLC v. Bluebird Bio Inc | 10/21/21 | ||
| 4:20-CV-08624 | AbCellera Biologics Inc v. Bruker Cellular Analysis Inc | 12/07/20 | Patent Owner | |
| 2:20-CV-12470 | Alkermes Inc v. Teva Pharmaceutical Industries USA Inc | 09/09/20 | Patent Owner | |
| 3:20-CV-03106 | Mitsubishi Tanabe Pharma Corp v. Aurobindo Pharma USA Inc | 03/20/20 | ||
| 3:17-CV-12082 | Mitsubishi Tanabe Pharma Corp v. Aurobindo Pharma USA Inc | 11/27/17 | ||
| 3:17-CV-06375 | Mitsubishi Tanabe Pharma Corp v. Invagen Pharma Inc | 08/23/17 | ||
| 1:17-CV-01065 | AbbVie Inc v. Boehringer Ingelheim Intl GmbH | 08/02/17 | ||
| 3:17-CV-05319 | Mitsubishi Tanabe Pharma Corp v. Sandoz Inc | 07/20/17 |